Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Trastuzumab with CAPOX in HER2-positive Advanced Gastric Cancer
NCT05997524Phase 2Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Mar 2021
- Primary completion
- Feb 2022
- Modality
- Engineered Antibody Formats, Antibody Conjugates, Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of trastuzumab in gastric cancer (GC), sponsored by Bangabandhu Sheikh Mujib Medical University. Started Mar 2021; status: completed.
02
Drugs
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on NCT05997524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05997524.